Rapid in Silico Design of Antibodies Targeting SARS-CoV-2 Using Machine Learning and Supercomputing

doi 10.1101/2020.04.03.024885
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Humanized Single Domain Antibodies Neutralize SARS-CoV-2 by Targeting Spike Receptor Binding Domain

2020English

Fully Human Single-Domain Antibodies Against SARS-CoV-2

2020English

RT‐LAMP for Rapid Diagnosis of Coronavirus SARS‐CoV‐2

Microbial Biotechnology
Applied MicrobiologyBiotechnologyBiochemistryBioengineering
2020English

Detection of Antibodies Against SARS-CoV-2 in Patients With COVID-19

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2

2020English

Accurate Identification of SARS-CoV-2 From Viral Genome Sequences Using Deep Learning

2020English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients

2020English

In Silico Study of the Spike Protein From SARS-CoV-2 Interaction With ACE2: Similarity With SARS-CoV, Hot-Spot Analysis and Effect of the Receptor Polymorphism

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy